Related by context. All words. (Click for frequent words.) 67 Portfolio License 64 Intellectual Property Portfolio 62 Patents Issued 61 Cross Licensing Agreement 61 AVC Patent 61 TM MMP Portfolio 61 Cross License Agreement 60 Secures Patent 60 Issued Patent 60 Patent Issued 60 Acacia Subsidiary Acquires 60 Patents Covering 60 Begins Shipment 59 Files Patent Infringement 59 Settle Patent Litigation 59 Non Infringement 59 Files Provisional 59 ULDAGE 59 Announce License Agreement 58 Patent Licensing 58 Acacia Subsidiary 58 Settles Patent Litigation 58 Licensing Agreements 58 Receives Patent 58 Patent Lawsuit 58 Patent Infringement 57 Exclusive License 57 Announces FDA Clearance 57 Patent Infringement Litigation 57 Distribution Agreements 57 Patent License Agreement 57 Expand Collaboration 57 Files Patent 57 Patent Covering 57 Video Codec 57 Patent Infringement Lawsuit 57 Patent Infringement Suit 56 Files Patent Application 56 Obtains Exclusive License 56 Wins Patent Infringement 56 Significantly Expand 56 CORE Flash 56 Obtains Patent 56 Misonix Announces 55 Announce Interoperability 55 Awarded Patents 55 Key Milestones 55 Drug Candidate 55 Initiates Patent Infringement 55 Sign License Agreement 55 Patented Technology 55 Inks Licensing Deal 55 Method Developed 55 Announces Licensing Agreement 55 Licensing Pact 55 Patent Lawsuit Against 55 Accelerate Commercialization 55 Completes Patient Enrollment 55 Patent Upheld 55 Patent Infringement Case 55 Commercializes 55 Biomarker Study 55 Magnetoresistive Random Access 54 Unsolicited Proposal From 54 Flagship Product 54 Patent Infringement Lawsuit Against 54 Settle Litigation 54 Pending Litigation 54 Acacia Subsidiary Enters 54 NASDAQ Listing Requirements 54 Patent Dispute 54 Immunomedics Announces 54 Commercially Available 54 BioElectronics Corporation Announces 54 Doubles Capacity 54 Expands Portfolio 54 Patent Licensing Agreement 54 Taglich Brothers Initiates Coverage 54 Announces License Agreement 54 Sublicense Agreement 54 Acquires Exclusive 54 Taro Receives 54 Sign Licensing Agreement 54 Initiates Clinical Trial 54 Settles Litigation 53 purchased Moore Microprocessor 53 Announce Commencement 53 Licensing Deal 53 Achieves Milestone 53 Enters Into Exclusive 53 Files IND 53 MMP Portfolio license 53 License Option Agreement 53 Memory MRAM 53 Vigorously Defend 53 Pending Acquisition 53 Presents Preclinical Data 53 Awarded Patent 53 Receives Orphan Drug Designation 53 Strengthens Balance Sheet 53 Infringes 53 Patents Upheld 53 Clinical Trial Results 53 Therapeutic Antibody 53 Extend Collaboration 53 Dramatically Expands 53 Enters Into Licensing Agreement 53 Initiates Clinical 53 JAK2 Inhibitor 53 Milestone Payment 53 Announces Immediate Availability 53 Settles Patent 53 Receives FDA Clearance 53 Regains NASDAQ 53 Licenses Novel 53 Files Patents 53 Settles Patent Dispute 53 Signs Licensing Agreement 53 Finalize Agreement 53 Board Authorizes 53 Strengthens Position 53 Patent Infringement Claims 53 Patent Litigation 53 Broadens Scope 53 Dramatically Increases 53 Wafer Supply 53 Obtains Exclusive 53 Receives NASDAQ 53 Restructures Debt 53 Qflix TM 52 Announces Initiation 52 Patent Validity 52 Present Preclinical Data 52 Report Analyzes 52 Receives Milestone Payment 52 Announce Licensing 52 Signs License Agreement 52 Tablet Device 52 Recordable Media 52 Purchases Moore Microprocessor 52 Settles Patent Infringement Lawsuit 52 Tumor Targeting 52 Demonstrates Commitment 52 Develop Novel 52 Receives CE Marking 52 Commercialization Agreement 52 Initiates Enrollment 52 FDA Clears 52 called Microstructure Chromatograph 52 Mutually Agree 52 MobileMedia 52 Subsidiary Enters 52 3D Interconnect 52 Uses Thereof 52 News Unternehmensnachrichten DGAP Adhoc 52 Streamlines Operations 52 Patent Infringement Suit Against 52 Gets FDA Clearance 52 HSR Waiting Period 52 Nanophase Announces 52 Sublicense 52 Pandemic Influenza Vaccines 52 Explore Strategic Alternatives 52 Settle Patent 52 Reexamination Certificate 52 Supply Agreements 52 Milestone Payments 52 AVI BioPharma Announces 52 Infringement Case 52 Infringe 52 Strengthens Its 52 Announce Collaboration 52 Via Licensing 52 Flamel Technologies Announces 52 Broadens Its 52 Completes Enrollment 52 NASDAQ Delisting 52 License Pact 52 TRANSDUR ™ 52 Exclusive Licensee 52 Reduces Cost 52 Integra LifeSciences Announces 52 Inks Deals 52 RNAi Therapeutics 52 Terminates Merger Agreement 52 Study Validates 52 Patent Infringement Action 52 Secures Exclusive 52 Small Molecule 52 FCC Approves 52 Extends Collaboration 52 Nasdaq Listing Requirements 52 Develop Next Generation 52 Achieves Significant 52 Recombinant Protein 52 Copy Protection 52 Expands Capabilities 52 Patent Suit 52 Announcement acc 51 Unveils Revolutionary 51 Acquire Assets 51 Successful Completion 51 DARA logo 51 Worldwide Licensing Agreement 51 Announces Definitive Agreements 51 Announces Issuance 51 Antitrust Settlement 51 Receives Favorable Ruling 51 Commences Consent Solicitation 51 Royalty Rates 51 Submits IND 51 Enters Negotiations 51 ProChon Biotech 51 Unveils Expanded 51 Shelf Registration Statement 51 SecuTech 51 ASNAP 51 Amends Agreement 51 Patent Reexamination 51 Enhanced Capabilities 51 Infringed 51 Announce Collaboration Agreement 51 Completes Recapitalization 51 Regains Full 51 Significantly Increases 51 Explores Strategic Alternatives 51 POTELLIGENT R Technology 51 Definitive Agreements 51 Reacquires 51 Regains Compliance 51 Receives Clearance 51 Non Discriminatory 51 Provides Update Regarding 51 Submits NDA 51 Enters Into Distribution 51 Inks License 51 Exclusive Licensing 51 Secures Financing 51 Receives Notification 51 Teva Provides Update 51 Differentiates 51 Jointly Develop 51 Reduces Size 51 AnaSpec Introduces 51 www.vialicensing.com 51 Gets Clearance 51 Settle Patent Dispute 51 Generic Version 51 CysDisplay R 51 Deliver Powerful 51 Delivers Next Generation 51 Announce Licensing Agreement 51 Synthetic Peptide 51 License Agreements 51 FDA Okays 51 Collaborators Publish 51 Solution Accelerates 51 Maximize Value 51 hi fn inc 51 Receives Commitment 51 Ucyclyd Pharma Inc. 51 Patent Portfolios 51 Systemic Delivery 51 Receives Favorable 51 Unveils Innovative 51 InterfeRx 51 Declaratory Judgment 51 Extends Leadership 51 Results Confirm 51 Optical Coatings 51 Announce Merger Agreement 51 Receives Funding 51 Enables Faster 51 GRAS Status 51 Acquire Controlling Interest 51 Receives ISO #:# [002] 51 Patent Suits 51 Expands Globally 51 Arbitration Proceeding 51 Successfully Concludes 51 Vicor Technologies Announces 51 ZapMedia applied 51 Exclusive License Agreement 51 Expand Relationship 50 Consummates 50 Executes Agreement 50 Concerns Arise 50 Patent Filing 50 Licenses Patents 50 Monetizes 50 Metabolic Disorder 50 Platform Enables 50 Announces Favorable Ruling 50 Announce Settlement 50 Lung Cancer Drug 50 Regains Nasdaq 50 Enables Easy 50 Receives Orphan Drug 50 Proves Successful 50 Expands Availability 50 Antibody Discovery 50 Helps Ensure 50 Schweitzer Mauduit Announces 50 Gets Favorable Ruling 50 Announces Dismissal 50 Submits Application 50 ARM Processors 50 Settles Patent Suit 50 Ichor Medical Systems 50 Act ERISA Breach 50 Patent Ruling 50 Obtains License 50 Extend Partnership 50 Complete Merger 50 Sorenson Spark 50 Ink Pact 50 Gout Drug 50 Enters Into Long Term 50 Software Simplifies 50 Material Definitive Agreement 50 Receives Confirmation 50 HuCAL PLATINUM R 50 '# Patent 50 Secures Long Term 50 Nicotine Vaccine 50 Unveils Next Generation 50 Starts Shipping 50 Spins Off 50 Alanco Announces 50 Patent Issuance 50 microRNA Therapeutics 50 Announces Discontinuation 50 Significant Milestones 50 Secures Additional 50 Handset Manufacturers 50 Supplemental Biologics License Application 50 Financing Transactions 50 OFDM OFDMA 50 SES ASTRA Signs 50 commercializing Loramyc ® 50 Restate Financials 50 Announce Joint Venture 50 Expands Scope 50 Stockwire.com OTC 50 Corporation SiGen 50 Inhaled Insulin 50 Announce Successful Completion 50 entitled Compositions 50 Obtains Exclusive Rights 50 Derma Sciences Announces 50 Receives ISO #:# [001] 50 Reach Settlement Agreement 50 Finalizes Plans 50 Inc Therapeutic Competitors 50 BiTE Antibody 50 Sarnoff TakeCharge 50 NMP# ® 50 Alliacense 50 microQ 50 Completes Tender Offer 50 Enters Into Definitive 50 Expands Internationally 50 ELADUR TM 50 www.nano 50 Shareholder Investigation 50 Nasdaq Delisting Notice 50 Signs Agreements 50 Signs Non Binding 50 Provides Shareholder 50 Generic Versions 50 Seabed Logging 50 Initiates Phase II 50 Trends Influencing 50 Announces Definitive Agreement 50 Rheumatoid Arthritis Drug 50 Implantable Medical 50 Reaches Settlement Agreement 50 Monoclonal Antibody 50 Psoriasis Drug 50 Licensing Agreement 50 Vaccine Adjuvants 50 www.enwave.net 50 EMD Biosciences Inc. 50 Jointly Developed 50 Signs Definitive 50 Announces Tentative Approval 50 Introduces Next Generation 50 www.sensio.tv 50 Patent Disputes 50 Jos. Schneider 49 Enters Into License Agreement 49 Formalizes 49 Restructures Operations 49 Develop Innovative 49 Patent Infringements 49 Becomes Effective 49 Acquire Privately Held 49 MultiMediaCard Association 49 Arthritis Drug 49 Wins Approval 49 Amend Merger Agreement 49 Regulatory Clearance 49 DGDM 49 Protein Synthesis 49 BioSante Pharmaceuticals Announces 49 FabricStream 49 Fixed Dose Combination 49 Enters Into Joint Venture 49 AdvanSource Biomaterials Announces 49 Debuts Next Generation 49 HuCAL ® 49 S3 onHandTV 49 Patent Suit Against 49 Seasonal Influenza Vaccine 49 Diagnostic Tests 49 Ercole Biotech 49 please visit http:/www.srslabs.com 49 Q2 Loss Narrows 49 Nippon Kayaku 49 Provides Clarification 49 Awarded GSA Schedule 49 Confirms Commitment 49 LecTec Corporation 49 patent EP# 49 mp3 SURROUND 49 HLNAND 49 Clinical Trial Data 49 Signs Option Agreement 49 Presents Positive Preclinical 49 Gene Expression Analysis 49 Mylan Receives Approval 49 UnityOne logo 49 Stock Buyback Program 49 Inks Distribution 49 Wins Summary Judgment 49 Drug Coated Stent 49 Announce Availability 49 Finalizes Acquisition 49 Further Validates 49 Expands Distribution 49 DOR BioPharma Announces 49 Files Patent Infringement Suit 49 Frequency Bands 49 subsidiaries visit http:/www.apricusbio.com 49 Captisol ® 49 Receives SFDA Approval 49 Jointly Announce 49 For Undisclosed Terms 49 Technological Advances 49 Fortifies 49 Jointly Offer 49 Miraculins Announces 49 Markettelegraph.com 49 NASDAQ LDIS 49 ZaBeCor 49 DIAGNOS Announces 49 Nihon Kohden Corporation 49 please visit www.edigital.com 49 MOTOROLA Motorola 49 Bavarian Nordic patented 49 CryptoFirewall 49 Equipment Deals 49 System VRB ESS 49 Progenitor Cell 49 Electronic Passports 49 Global Reseller Agreement 49 Microfluidic Systems 49 Taisho Pharmaceuticals 49 Resolves Dispute 49 Significant Milestone 49 Summary Judgment Order 49 Patent Invalid 49 Fortical ® 49 Tactile Feedback 49 Barcode Scanning 49 Idenix Novartis 49 Chip Makers 49 Markman Ruling 49 Distributor Agreement 49 Stock Repurchase Plan 49 #,#,# B2 49 VNUS patents 49 PDUFA Date 49 CodecSys TM 49 Keith Bergelt CEO 49 oligonucleotides Manoharan 49 Prometheus Laboratories 49 Therapeutic Competitors Companies 49 Obtains Financing 49 ASX BLT 49 Terminate Agreement 49 Momentum Continues 49 Previously Announced Private Placement 49 Director Shareholding 49 sanofi aventis Novartis 49 Exclusive Licensing Agreement 49 Receives Complete Response 49 Expanded Indication 49 Enters Strategic 49 Receive Milestone Payment 49 Initiates Dosing 49 Completes Previously Announced 49 Files Shelf Registration Statement 49 TOP Ships Announces 49 Approves Share Repurchase 49 Antithrombin 49 Patents 49 Stockholders Approve Merger 49 NYSE Amex Listing 49 Signs Merger Agreement 49 Enable Secure 49 DVD6C 49 WiLAN founded 49 No. RE# [001] 49 Receives Unsolicited 49 Commercialize 49 Definitive Merger Agreement 49 Unveils Groundbreaking 49 DVD6C Licensing Group 49 Earns Milestone Payment 49 Accelerates Expansion 49 Polysilicon Supply Agreement 49 Infringement Suit 49 Obtains Approval 49 Protein Biomarkers 49 HuCAL GOLD R 49 Medicure Announces 49 Arbitration Agreements 48 Begins Shipping 48 Patentability 48 Rectangular Column 48 Expands Functionality 48 Uracyst R Test 48 Data Suggest 48 Patent Infringement Claim 48 Secures Funding 48 METHOD FOR 48 www.3dsyndication.com 48 Announces Debt Settlement 48 Waiver Agreement 48 Therapeutic Competitors Report 48 MIFARE4Mobile 48 FDA Approvals 48 Forgent intellectual property 48 Announces Intent 48 Transdermal Drug 48 Predictive Snooping technology 48 NanoTherapies 48 Kreutzer Limmer patent 48 Unveils Newest 48 Improves Efficiency 48 Inc. dba Vitro 48 Signs Licensing 48 Loramyc ™ 48 Announces Expanded 48 Further Strengthens 48 Completes Asset 48 PharmaStem 48 Certicom ECC 48 Favorable Ruling 48 Diamyd Medical Diamyd 48 Extends Tender Offer 48 Analog Switch 48 VIVITROL ® 48 Aradigm Logo 48 Completes Reverse Merger 48 Announces Shareholder Approval 48 Achieves ISO #:# Certification [002] 48 Exclusivity Agreement 48 Pandel R 48 Fingerprint Biometric 48 Enters Joint Venture 48 DPA countermeasures 48 Unsolicited Tender Offer 48 Acquisition Proposal 48 Reduces Debt 48 Issues Shareholder 48 Corporation Nasdaq MVSN 48 Retains CCG Investor Relations 48 Insulin Pen 48 Option Grants 48 Anti CD# Antibody 48 Enters Into Partnership 48 Microwave Ablation System 48 Offers Unprecedented 48 Doubles Size 48 DVD Copying 48 Permanent Injunction 48 Introduces Enhanced 48 Strengthens Commitment 48 Proxy Proposals 48 Association OSTA 48 Fully Functional 48 VCS Verification Library 48 ipIQ 48 include Afa Technologies 48 Alligator Bioscience AB 48 Finalizes Agreement 48 Attorneys Fees 48 Completes Divestiture 48 Discontinues 48 foundational patents 48 Subsidiary Wins 48 Announce Early Termination 48 BOTHELL Wash. Business Wire 48 please visit www.srslabs.com 48 Sign Definitive Agreement 48 BSKB 48 Visual Voicemail patents 48 Trademark Dispute 48 resolves patent infringement 48 Order Approving 48 Inks Licensing Agreement 48 Distribution Pact 48 Files Patent Infringement Lawsuit 48 Successfully Completed 48 WebTech Wireless Announces 48 euro adhoc Intercell AG 48 Announces Enhancements 48 sublicensed 48 Corporation NASDAQ MVSN 48 Subsidiary Receives 48 Announces Cancellation 48 Inks Pact 48 Awarded Contracts 48 Enterprises CLE 48 Receives Certification 48 Signs Distribution 48 Enters Into Definitive Agreement 48 Helicos BioSciences Announces 48 Qualcomm GSM WCDMA 48 Completes Transition 48 Nasdaq XTLB 48 Visual Voicemail patent 48 O2Micro Granted 48 Quantum Dots 48 Enter Into 48 Testosterone Gel 48 Inc. AMEX CTT 48 Patent Broadly Covering 48 Pad Printing 48 Executes Letter 48 Preliminary Injunction Against 48 Announces Successful Completion 48 Physical Layer PHY 48 Patent Filings 48 FDA Accepts 48 Granted Orphan Drug 48 Subsidiary Signs 48 Manufacturer Selects 48 Tortious Interference 48 Receives Marketing Authorization 48 CEVA SATA 48 Issues Resolved 48 Justsystem 48 ZBx 48 Eliminates Need 48 MOSAID patents 48 Furthers Its 48 PRNewswire FirstCall CEVA 48 Terminates Agreement 48 Spins Out 48 SPI Dynamics Incorporated 48 Resubmit 48 Enters Into Strategic 48 VentiRx Pharmaceuticals 48 Stem Cell Patents 48 Provisional Patent 48 Compulsory License 48 Nears Launch 48 VoiceStick ® 48 Fluidigm Corporation 48 Issues Clarification 48 Kreutzer Limmer 48 nonexclusive license 48 Automation Capabilities 48 Sisvel 48 Amends Terms 48 Settlement Agreement Regarding 48 Ampex Corporation 48 CysDisplay 48 Significantly Expands 48 Genes Involved 48 Authorized Generic 48 Flexpoint Announces 48 OTC Bulletin Board TENF 48 Runcom Technologies Ltd. 48 Closes Merger 47 Lowers Costs 47 Quark Biotech 47 siRNA Delivery 47 Completes Financing 47 Ramps Up Production 47 Expand Scope 47 DayTradersDigest.com Profiles 47 3G Handset 47 Emission Reductions 47 Updates Shareholders 47 Confirms Filing 47 M2M Modules 47 Engine VEE 47 LiverPool 47 Vertebral Fracture 47 Nasdaq ACTG announced 47 Refinances Debt 47 Introduces Innovative 47 CapGen Offering 47 Technology Licensing QTL 47 DLNA Certification 47 Announce Agreement 47 Investigational Agent 47 Mersana Therapeutics Inc. 47 Balance Sheet Restructuring 47 Markets Examine 47 Completes Restructuring 47 ibuprofen gel 47 Complies 47 Hip Prosthesis 47 Blood Clotting 47 Dynepo TM 47 Regulatory Approvals 47 Vendum Batteries 47 Announces Termination 47 Clears Path 47 Files Trademark 47 ICANN Approves 47 Emblaze VCON 47 Settles Charges 47 Durect Corporation 47 Announce Expiration 47 embedded FRAM 47 RAZADYNE R 47 ALLEGRA ® 47 Latest Versions 47 Completes Private Placement 47 Directors Authorizes 47 include DSM Biologics 47 Successfully Passes 47 Moves Towards 47 Turbo EPON 47 Initiates Voluntary 47 Could Pave Way 47 Permanent Injunction Against 47 Inequitable Conduct 47 Completes Purchase 47 SAFLUTAN 47 b#x# http:/#.#.#.#/fls.geo/PH #x# #.hyahrtzeit 47 MICRODUR TM 47 Ltd. TASE ELRN 47 POTELLIGENT R 47 OTCBB ENTB 47 Growing Rapidly 47 GenWay Biotech 47 Primus Pharmaceuticals 47 CoCreate Software GmbH 47 Enters Into Settlement Agreement 47 Provides Status 47 Settles Dispute 47 NASDAQ Deficiency Notice 47 Ltd Therapeutic Competitors 47 Q3 Loss Narrows 47 Broadens 47 Begin Clinical Trials 47 NanoInk logo 47 Patent Infringement Complaint 47 grant sublicenses 47 Therapeutic Competitors companiesandmarkets.com adEgemonye 47 Trademark Infringement Lawsuit 47 Enters Into Collaboration 47 '# patents 47 Presents Positive 47 Successfully Integrates 47 DiiVA Consortium 47 UCB Pharma SA 47 RECOTHROM R 47 Merger Transaction 47 SulphCo Announces 47 No. #.# 47 Patent Spat 47 IPSEN 47 ExonHit Therapeutics SA 47 Broadcom Completes Acquisition 47 Sign Definitive Merger 47 Receives Approvals 47 Summary Judgment Motions 47 VIOXX Product 47 MorphoSys proprietary 47 nasal calcitonin product 47 CardXX 47 Inks Supply 47 UFood Grill Announces 47 :/ finance.yahoo.com q 47 Miscellaneous #.#.# Release 47 Resale Registration Statement 47 Distributorship Agreement 47 Collaborates With 47 OTCBB APCSF 47 Bupropion HCl ER 47 Helix BioMedix Inc. 47 WARF stem cell 47 Remain Listed 47 Receives Positive 47 AMEX RGN 47 Closes Previously Announced 47 Ink Deal 47 Announces Spin Off 47 Reexamination 47 Terminate Merger 47 DURECT Corporation 47 Shareholder Suits 47 Announce Exclusive 47 RainStorm 47 Inks Exclusive 47 Declares Dividend Quick Facts 47 Acquire Majority 47 Migraine Drug 47 Generic Protonix 47 Methylphenidate Transdermal System 47 VoiceAge Corporation 47 Enters Beta 47 MOSAID Technologies Inc. 47 Antitrust Violations 47 Liability Lawsuits 47 rxRNA 47 Use Thereof 47 Jim DeRouchey President 47 Extend Relationship 47 Sell Itself 47 Synerx 47 Aptamer 47 FLEXnet Publisher 47 Signs Binding 47 Seeks Approval 47 Reaches Agreements 47 ARM# MPCore 47 Receives Fast Track 47 Receives Notice 47 TRANSDUR TM 47 Exclusive Distribution 47 Tekturna Rasilez 47 Patent Application 47 Signs Binding Letter 47 Clean Diesel patented 47 Hyperion Catalysis International 47 OJAI Calif. BUSINESS WIRE 47 OTCBB LECT announced 47 License Agreement 47 Study Recommends 47 Nationwide Voluntary Recall 47 Successfully Complete 47 Legally Binding 47 Injunctive Relief 47 Lupus Drug 47 Quadruples 47 Alseres Pharmaceuticals Inc. 47 GTC NASDAQ GTCB 47 TCG Opal specification 47 Anti Nausea 47 Confidentiality Agreements 46 Influenza Vaccine Production 46 Asset Swap 46 Taps Lobbyist 46 homocysteine assay 46 Jacada Signs 46 Anemia Drug 46 Oligonucleotide 46 Trademark Lawsuit 46 NasdaqGM SPPI 46 Exercises Option 46 Nasdaq Delisting Notification 46 Nano Scale 46 Cholesterol Lowering Drug 46 Protease Inhibitor 46 DataTern 46 Transfer Agreement 46 licensable IP 46 RapMAT R 46 Inc. LATEST NEWS 46 Extends Reach 46 Slashes Price 46 OTCBB NPHC 46 Botanical Reference 46 NASDAQ CRXL 46 Frank Evanshen CEO 46 Shimadzu Corporation 46 Stockholder Approval 46 Header Compression 46 Methylnaltrexone 46 4Q Loss Widens 46 Broadest Range 46 visit networks.com 46 www.twitter.com shamrockstocks -www.shamrockstocks.com About 46 Extends Term 46 Avian Flu Vaccine 46 Treating Chronic 46 Q3 Loss Widens 46 Countersuit 46 Announces Effective Date 46 NovaRx Corporation 46 Adroit Resources Inc. 46 Arasan Chip Systems 46 Renews Exclusive 46 Forges Ahead 46 Molecular Diagnostic 46 Reports Receipt 46 Completes Integration 46 non infringement invalidity 46 MBMI Closes 46 Fresenius Biotech 46 Electroporation 46 Signs MOU 46 Teaming Agreement 46 Oral Calcitonin 46 Pending Merger 46 Authorized Reseller Program 46 Remains Committed 46 OTCBB HXBM developer 46 Obtains FDA 46 Quantum Cryptography 46 Successfully Tests 46 Must Carry 46 Announces Proposed Acquisition 46 Tuschl 46 M 3DI 46 MSON 46 Copyright Infringement 46 DesignWare Verification Library 46 exclusive sublicense 46 capacitive touch controller 46 nSys 46 Low Dose 46 Fold Increase 46 Launches Redesigned Website 46 Completes Acquisitions 46 Optical Storage 46 SKYFIBER 46 CORLUX CORT # 46 Receives Tentative FDA 46 Biotech Firm 46 BXT # 46 Modem Card 46 Asentar TM 46 mark eOn 46 Ethical Considerations 46 Confirms Validity 46 Non Binding Letter 46 MetaCarta Incorporated 46 Oracea TM 46 Generic Version Of 46 InStorage REIT Announces 46 NASDAQ Listing 46 Breast Cancer Genes 46 Blood Thinner 46 #GPP/#GPP# 46 OTCBB IGXT 46 HIV Integrase 46 Widely Available 46 Inovio Pharmaceuticals 46 Testosterone Patch 46 Saflink Corporation 46 NASDAQ DRRX 46 Hextend R 46 Patent Infringement Lawsuits 46 GlaxoSmithKline MedImmune 46 Blood Pressure Drug 46 Binding Agreement 46 Awarded GSA 46 Osteoporosis Drug 46 Previously Announced 46 Biometric Identity 46 Breakthroughstocks.net EXPLOSIVE news 46 Entocort 46 PRN FreeStar Technology 46 Secure.Data 46 Wider Networks 46 visit smith.com 46 Antitrust Probe 46 Derivative Action 46 patents 46 PlayReady DRM 46 Advanced Colorectal Cancer 46 #.#.# Meldung [001] 46 Corporation Nasdaq ACTG 46 Announces Additions 46 Announces Latest Version 46 DTL patent 46 Reseller Relationship 46 Announces Reverse Split 46 Watermarking 46 Shareholder Lawsuits 46 Patriot Act Provisions 46 Inks LOI 46 Analogs 46 TapImmune Inc. 46 Licence Agreements 46 Aviza Technology Announces 46 Derivative Works #.# 46 Vitamin D analogue 46 Announce Expanded